tirzepatide press release A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.⁠ ⁠ The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or What other health conditions are

Approval could enable healthcare providers to add retatrutide to their toolbox when treating obesity, particularly for individuals who have not responded to other treatments

RxAngels Pay it Forward Program A First of Its Kind pharmacy program that allows you to Pay it Forward for those in our community who cannot afford their essential monthly medications

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month planyour dose may need to go up, but your price won't

By ensuring L-Lysine sufficiency, patients provide their B-cells with the necessary components to manufacture these critical defense molecules

Antibiotics : Your healthcare provider may prescribe one or more antibiotics to take at home